Acorda Therapeutics, Inc.
(NASDAQ : ACOR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.62%183.301.3%$515.79m
CELGCelgene Corporation
-0.61%92.621.3%$442.98m
ARRYArray BioPharma Inc.
-0.26%46.098.1%$437.02m
GILDGilead Sciences, Inc.
-1.17%67.680.9%$395.57m
BIIBBiogen Inc.
-1.44%236.831.3%$373.10m
ILMNIllumina, Inc.
-0.68%355.633.5%$304.33m
REGNRegeneron Pharmaceuticals, Inc.
-3.10%303.212.6%$239.55m
VRTXVertex Pharmaceuticals Incorporated
-1.01%178.331.9%$214.81m
ALXNAlexion Pharmaceuticals, Inc.
-0.68%124.302.0%$204.89m
EXASExact Sciences Corporation
0.64%112.1624.1%$190.27m
AAgilent Technologies, Inc.
-0.33%72.271.6%$156.70m
BMRNBioMarin Pharmaceutical Inc.
-0.79%83.164.3%$126.70m
SRPTSarepta Therapeutics, Inc.
3.70%128.7514.7%$117.49m
INCYIncyte Corporation
-2.19%85.692.5%$113.30m
MRTXMirati Therapeutics Inc.
-4.31%97.742.5%$102.89m

Company Profile

Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its two main products are Ampyra and Zanaflex Capsules. The Ampyra is an oral drug, which treats to improve walking in patients with multiple sclerosis and Zanaflex Capsules, which is a short acting drug for the management of spasticity, a symptom of many central nervous system disorders, including multiple sclerosis and spinal cord injury. The company was founded by Ronald Cohen in 1995 and is headquartered in Ardsley, NY.